Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

5.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.4K
Veins of Head and Neck01:19

Veins of Head and Neck

4.3K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
4.3K
Arteries of the Head and Neck01:26

Arteries of the Head and Neck

2.4K
The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
2.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311.

JCO oncology advances·2026
Same author

Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

Cancer·2026
Same author

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC.

Future oncology (London, England)·2026
Same author

STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma.

JNCI cancer spectrum·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Nov 28, 2025

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.1K

Head and neck squamous cell carcinoma.

Daniel E Johnson1, Barbara Burtness2, C René Leemans3

  • 1Department of Otolaryngology-Head and Neck Surgery, University of California at San Francisco, San Francisco, CA, USA.

Nature Reviews. Disease Primers
|November 27, 2020
PubMed
Summary
This summary is machine-generated.

Head and neck squamous cell carcinoma (HNSCC) is categorized by HPV status, impacting diagnosis and treatment. Advances in understanding HNSCC molecular genetics offer new therapeutic avenues and biomarker development for personalized care.

More Related Videos

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.8K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.1K

Related Experiment Videos

Last Updated: Nov 28, 2025

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.1K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.8K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Epidemiology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) originates from mucosal epithelium.
  • HNSCC is classified as HPV-negative (linked to tobacco/alcohol) or HPV-positive (linked to HPV-16).
  • Most patients present with late-stage HNSCC, often without a clear pre-malignant lesion.

Purpose of the Study:

  • To review the current understanding of HNSCC classification, staging, and treatment.
  • To highlight the impact of human papillomavirus (HPV) status on HNSCC.
  • To discuss emerging therapeutic strategies based on molecular genetic insights.

Main Methods:

  • Review of existing literature on HNSCC epidemiology, pathology, and treatment modalities.
  • Analysis of staging system evolution, including the 2017 AJCC/UICC system.
  • Summary of current and FDA-approved treatments, including chemotherapy, radiation, immunotherapy, and targeted therapy.

Main Results:

  • HNSCC can be divided into HPV-negative and HPV-positive subtypes with different etiological factors.
  • Treatment approaches vary based on cancer site, stage, and HPV status, including surgery, chemoradiotherapy, and immunotherapy.
  • Recent molecular discoveries are paving the way for novel targeted therapies and predictive biomarkers.

Conclusions:

  • Understanding HNSCC heterogeneity, particularly HPV status, is crucial for effective management.
  • Multimodal treatment strategies are standard, with immunotherapy showing promise in advanced HNSCC.
  • Future research focusing on molecular and immunobiology aims to personalize HNSCC treatment for improved outcomes.